Population-based type-specific prevalence of high-risk human papillomavirus infection in Estonia

BACKGROUND: Effective prophylactic vaccines are available against human papillomavirus (HPV) types 6, 11, 16, and 18 which are licensed for routine use among young women. Monitoring is needed to demonstrate protection against cervical cancer, to verify duration of protection, and assess replacement...

Descripción completa

Detalles Bibliográficos
Autores principales: Uusküla, Anneli, Kals, Mart, Kosenkranius, Liina, McNutt, Louise-Anne, DeHovitz J, Jack
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2841185/
https://www.ncbi.nlm.nih.gov/pubmed/20222944
http://dx.doi.org/10.1186/1471-2334-10-63

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2841185/
https://www.ncbi.nlm.nih.gov/pubmed/20222944
http://dx.doi.org/10.1186/1471-2334-10-63

Ejemplares similares